Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Brazilian Red Propolis contains unique prenylated isoflavones—vestitol, neovestitol, and medicarpin—derived primarily from Dalbergia ecastophyllum resin, which inhibit bacterial cell wall synthesis, suppress prostaglandin E2 production, and modulate NF-κB-mediated inflammatory cascades. A double-blind randomized clinical trial (PMID 34955484) demonstrated that a Brazilian red propolis dentifrice significantly reduced oral biofilm and gingival inflammation in orthodontic patients, while comprehensive reviews (PMID 35880944; PMID 29473533) confirm its broad-spectrum antimicrobial, anti-inflammatory, antioxidant, and cardiovascular-protective activities.
Reported Benefits (Provisional)
Origin & History
Brazilian Red Propolis (Apis mellifera) is a unique resinous substance collected by honeybees from the red mangroves and other specific flora, predominantly in the coastal mangrove forests of Northeast Brazil. This distinct propolis is highly valued for its exceptional concentration of prenylated flavonoids and other bioactive compounds, offering potent immune, anti-inflammatory, and cardiovascular support.
Research Narrative (Provisional)
A double-blind randomized clinical trial by Lotif et al. (2022) in the Journal of Oral Science (PMID 34955484) demonstrated that a Brazilian red propolis-containing dentifrice significantly improved gingival health and reduced bacterial plaque in orthodontic patients. An earlier randomized clinical trial by Furtado Júnior et al. (2020) in Evidence-Based Complementary and Alternative Medicine (PMID 32063987) confirmed clinical and microbiological benefits of red propolis dentifrice in the same population. Dos Santos et al. (2022) published a comprehensive review in the Journal of Food Biochemistry (PMID 35880944) detailing the anti-inflammatory mechanisms of Brazilian red propolis, including suppression of COX-2, iNOS, and pro-inflammatory cytokines TNF-α and IL-6. Additionally, Pires et al. (2024) in Chemical Biodiversity (PMID 39231299) characterized polyprenylated benzophenones from red propolis showing significant anticancer activity against multiple tumor cell lines, while Silva (2021) in Biology (PMID 33406745) reviewed propolis's cardiovascular therapeutic potential including vasorelaxation and lipid-lowering effects.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Prenylated flavonoids - Polyphenols - Isoflavones - Pterocarpans - Kaempferol
Reported Mechanism (Provisional)
Brazilian Red Propolis exerts its bioactivity primarily through isoflavonoids (vestitol, neovestitol, medicarpin) and pterocarpans that directly disrupt bacterial cell wall peptidoglycan synthesis and compromise fungal membrane ergosterol integrity, conferring broad-spectrum antimicrobial action. Its anti-inflammatory effects are mediated by inhibition of the NF-κB signaling pathway, suppression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression, and consequent reduction in prostaglandin E2 (PGE2), TNF-α, and IL-6 production (PMID 35880944). Polyprenylated benzophenones and formononetin activate Nrf2-dependent antioxidant response elements, upregulating heme oxygenase-1 (HO-1) and superoxide dismutase (SOD), which collectively protect against oxidative stress-mediated cellular damage (PMID 39231299). The cardiovascular benefits are attributed to pterocarpan-mediated endothelial nitric oxide synthase (eNOS) activation, promoting vasodilation, and inhibition of HMG-CoA reductase activity contributing to cholesterol regulation (PMID 33406745).
Clinical Narrative (Provisional)
Current evidence is based primarily on in vitro and preclinical studies, with limited human clinical trials available. Laboratory studies demonstrate significant antimicrobial activity with isolated compounds producing 23±1mm inhibitory zones against Staphylococcus aureus and 26±0mm against Candida albicans. While extensive in vitro research supports antimicrobial, anti-inflammatory, and antioxidant properties, human clinical data remains insufficient for definitive therapeutic claims. Regulatory agencies emphasize the need for standardized processing and dosing protocols before widespread medicinal use.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.